These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21245128)

  • 1. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis.
    Kuragano T; Itoh K; Shimonaka Y; Kida A; Furuta M; Kitamura R; Yahiro M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
    Nephrol Dial Transplant; 2011 Aug; 26(8):2663-7. PubMed ID: 21245128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.
    Kuragano T; Shimonaka Y; Kida A; Furuta M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
    Am J Nephrol; 2010; 31(6):534-40. PubMed ID: 20484891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
    Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
    Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
    Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study.
    Dellegrottaglie S; Sands RL; Gillespie BW; Gnanasekaran G; Zannad F; Sengstock D; Finkelstein F; Kiser M; Eisele G; Hinderliter AL; Levin NW; Cattan V; Saran R; Rajagopalan S
    Nephrol Dial Transplant; 2011 Sep; 26(9):2891-8. PubMed ID: 21562144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.
    Kyriazis J; Tzanakis I; Stylianou K; Katsipi I; Moisiadis D; Papadaki A; Mavroeidi V; Kagia S; Karkavitsas N; Daphnis E
    Nephrol Dial Transplant; 2011 Sep; 26(9):2971-7. PubMed ID: 21427069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
    Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
    Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC; Tsai WC; Chen JY; Huang JJ
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated iron metabolism in patients on hemodialysis.
    Nakanishi T; Hasuike Y; Otaki Y; Nanami M; Kuragano T
    Contrib Nephrol; 2015; 185():22-31. PubMed ID: 26023012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate.
    Peters HP; Laarakkers CM; Swinkels DW; Wetzels JF
    Nephrol Dial Transplant; 2010 Mar; 25(3):848-53. PubMed ID: 19854845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
    Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
    Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin.
    Malyszko J; Malyszko JS; Kozminski P; Mysliwiec M
    Ren Fail; 2009; 31(10):876-83. PubMed ID: 20030521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised?
    Covic A; Mardare N; Gusbeth-Tatomir P; Prisada O; Sascau R; Goldsmith DJ
    Nephrol Dial Transplant; 2006 Oct; 21(10):2859-66. PubMed ID: 16854850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of tumor necrosis factor-α downregulate antimicrobial iron transport protein, Nramp1, in chronic hemodialysis patients: a key factor for infection risk.
    Moriguchi R; Otaki Y; Hazeki S; Shimada T; Matsumoto A; Kakita N; Kaibe S; Kuragano T; Nonoguchi H; Masayoshi N; Hasuike Y; Nakanishi T
    Am J Nephrol; 2012; 35(4):372-8. PubMed ID: 22508410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease.
    Chue CD; Edwards NC; Davis LJ; Steeds RP; Townend JN; Ferro CJ
    Nephrol Dial Transplant; 2011 Aug; 26(8):2576-82. PubMed ID: 21248296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients.
    Sonnweber T; Theurl I; Seifert M; Schroll A; Eder S; Mayer G; Weiss G
    Nephrol Dial Transplant; 2011 Mar; 26(3):977-87. PubMed ID: 20826742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.